BioCardia, Inc. Proceeds from Stock Options Exercised
BioCardia, Inc. (BCDA) reported Proceeds from Stock Options Exercised of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-29
- BioCardia, Inc. proceeds from stock options exercised for the quarter ending 2022-12-31 was $0.00.
- BioCardia, Inc. proceeds from stock options exercised for the quarter ending 2022-09-30 was $0.00.
- BioCardia, Inc. proceeds from stock options exercised for the quarter ending 2022-06-30 was $0.00.
- BioCardia, Inc. proceeds from stock options exercised for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. proceeds from stock options exercised for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BioCardia, Inc. proceeds from stock options exercised for fiscal 2021 was $5.00K.
- BioCardia, Inc. proceeds from stock options exercised for fiscal 2020 was $0.00.
- BioCardia, Inc. proceeds from stock options exercised for fiscal 2018 was $4.00K, a 97.22% decline from fiscal 2017.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-29 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 derived: sum of 4 quarters · filed 2023-03-29 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 derived: sum of 4 quarters · filed 2023-03-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $5.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $5.00K 10-Q · filed 2022-11-09 | $5.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $5.00K 10-Q · filed 2022-08-10 | $5.00K derived: sum of 3 quarters · filed 2022-08-10 | $5.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-11 | $5.00K derived: sum of 2 quarters · filed 2022-05-11 | $5.00K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | |||
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | -$1.00K derived: sum of 2 quarters · filed 2020-04-09 | -$1.00K derived: sum of 3 quarters · filed 2020-04-09 | $4.00K 10-K · filed 2020-04-09 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $0.00 derived: sum of 2 quarters · filed 2019-11-19 | $5.00K 10-Q · filed 2019-11-19 | $123.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $5.00K 10-Q · filed 2019-08-14 | $123.00K derived: sum of 3 quarters · filed 2020-04-09 | $127.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-03-31 | $5.00K 10-Q · filed 2019-05-15 | $123.00K derived: sum of 2 quarters · filed 2020-04-09 | $127.00K derived: sum of 3 quarters · filed 2020-04-09 | $127.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2017-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $122.00K derived: sum of 2 quarters · filed 2020-04-09 | $122.00K derived: sum of 3 quarters · filed 2020-04-09 | $144.00K 10-K · filed 2020-04-09 |
| 2017-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.00K derived: sum of 2 quarters · filed 2018-11-08 | $26.00K 10-Q · filed 2018-11-08 | $46.00K derived: sum of 4 quarters · filed 2019-04-02 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $22.00K 10-Q · filed 2018-08-09 | $42.00K derived: sum of 3 quarters · filed 2019-04-02 | |
| 2017-03-31 | $22.00K 10-Q · filed 2018-05-10 | $42.00K derived: sum of 2 quarters · filed 2019-04-02 | ||
| 2016-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | $22.00K 10-K · filed 2019-04-02 | ||
| 2016-09-30 | $2.00K 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | $59.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |